Hims & Hers CTO sells 7,954 shares in planned trade

The CTO of Hims & Hers Health, Inc. sold shares under a pre-arranged Rule 10b5-1 trading plan, leaving a direct holding of 185,556 shares.

Available on EDGAR 09/17/2026 - 04:17 PM EDT Accepted by SEC EDGAR 09/17/2026 - 04:17 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Hims & Hers Health, Inc. (HIMS) reports that its Chief Technology Officer, Mohamed Elshenawy, sold 7,954 shares of Class A Common Stock on September 15, 2026 in a sale characterized as an open market or private transaction at $28.39 per share. After this transaction, he directly holds 185,556 shares. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 1, 2025 by the reporting person.

Insider Trade Summary 10b5-1

Net Seller: 7,954 shares

Net Sell 1 txn

Insider Elshenawy Mohamed

Role CTO

Sold 7,954 shs ($226K)

Share of Position Sold 4.1%

Type	Security	Shares	Price	Value
Sale	Class A Common Stock F1	7,954	$28.39	$226K

Holdings After Transaction: Class A Common Stock — 185,556 shares (Direct)

Holdings Before and After: Class A Common Stock, 193,510 to 185,556 shares (Direct)

Other Insiders: 4 other insiders reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (1)

1. F1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 1, 2025 by the Reporting Person.

Key Figures

Shares sold: 7,954 shares Sale price per share: $28.39 per share Shares held after transaction: 185,556 shares +2 more

5 metrics

Shares sold 7,954 shares Class A Common Stock sold by CTO on September 15, 2026

Sale price per share $28.39 per share Price for the 7,954 Class A Common shares sold on September 15, 2026

Shares held after transaction 185,556 shares Direct holdings of CTO Mohamed Elshenawy after the sale

Rule 10b5-1 plan adoption date December 1, 2025 Trading plan under which the reported sales were effected

Number of sell transactions 1 transaction Single reported sale of non-derivative Class A Common Stock

Key Terms

Rule 10b5-1 trading plan, Class A Common Stock, open market or private transaction, Reporting Person

4 terms

Rule 10b5-1 trading plan regulatory

"sales were effected pursuant to a Rule 10b5-1 trading plan adopted"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Class A Common Stock financial

"sold 7,954 shares of Class A Common Stock on September 15, 2026"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

open market or private transaction financial

"Sale in open market or private transaction"

Reporting Person regulatory

"trading plan adopted on December 1, 2025 by the Reporting Person"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did HIMS report for CTO Mohamed Elshenawy?

Hims & Hers Health, Inc. reported that CTO Mohamed Elshenawy sold 7,954 shares of Class A Common Stock on September 15, 2026 at $28.39 per share in an open market or private transaction.

How many HIMS shares does the CTO hold after the reported sale?

After the reported transaction, CTO Mohamed Elshenawy directly holds 185,556 shares of Hims & Hers Health, Inc. Class A Common Stock.

Was the September 15, 2026 HIMS insider sale under a Rule 10b5-1 plan?

Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted on December 1, 2025 by the reporting person, indicating they were made under a pre-arranged trading plan.

What price did the HIMS CTO receive per share in the September 15, 2026 sale?

The Hims & Hers Health, Inc. Form 4 reports that CTO Mohamed Elshenawy sold the 7,954 shares at a price of $28.39 per share in the transaction on September 15, 2026.

What type of security did the HIMS CTO sell in this Form 4 transaction?

The reported transaction by Hims & Hers Health, Inc. CTO Mohamed Elshenawy involved Class A Common Stock, designated as a non-derivative security in the Form 4 data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Elshenawy Mohamed

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CALIFORNIA 94123

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CTO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/15/2026		S(1)		7,954	D	$28.39	185,556	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 1, 2025 by the Reporting Person.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Mohamed Elshenawy	09/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)